These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 782699
1. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. Douglass HO, Lavin PT, Moertel CG. Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699 [Abstract] [Full Text] [Related]
2. Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer. Berman R, Giles GR, Malhotra A, Bird GG, Gajjar PD, Bunch GA, Hall R. Cancer Treat Rep; 1978 Mar; 62(3):457-9. PubMed ID: 348316 [No Abstract] [Full Text] [Related]
3. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer. Baker LH, Vaitkevicius VK, Gehan E. Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013 [Abstract] [Full Text] [Related]
4. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel. Posey LE, Morgan LR. Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750 [Abstract] [Full Text] [Related]
9. Sequential and combination chemotherapy of advanced gastric cancer. Moertel CG, Mittelman JA, Bakemeier RF, Engstrom P, Hanley J. Cancer; 1976 Aug; 38(2):678-82. PubMed ID: 788891 [Abstract] [Full Text] [Related]
10. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma. Abdallah AM, Soukop M, Bell G, Calman KC. Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430 [No Abstract] [Full Text] [Related]
11. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer. Buroker T, Wojtaszak B, Dindogru A, DeMattia M, Baker L, Groth C, Vaitkevicius VK. Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398 [Abstract] [Full Text] [Related]
13. Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination. Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG. Cancer Treat Rep; 1976 Jun; 60(6):729-32. PubMed ID: 954012 [No Abstract] [Full Text] [Related]
17. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study. White LA, Perry MC, Kardinal CG, Kennedy BJ, Weiss RB, Carey RW. Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497 [Abstract] [Full Text] [Related]
18. Combination chemotherapy with 5-fluorouracil and methyl-CCNU for the treatment of advanced gastrointestinal cancer. Brutti A, Liberati AM, Biscottini B, Fatati G, Sini S, Barzi AM, Grignani F. Tumori; 1979 Jun 30; 65(3):339-44. PubMed ID: 462584 [Abstract] [Full Text] [Related]
19. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma. Cedermark BJ, Kaufman JH, Douglass HO, Mittelman A. Clin Oncol; 1977 Mar 30; 3(1):27-31. PubMed ID: 862274 [No Abstract] [Full Text] [Related]
20. Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275). Douglass HO, Lavin PT, Evans JT, Mittelman A, Carbone PP. Cancer Treat Rep; 1979 Aug 30; 63(8):1355-7. PubMed ID: 476709 [Abstract] [Full Text] [Related] Page: [Next] [New Search]